Literature DB >> 25523964

Medication non-adherence in essential tremor.

Elan D Louis1.   

Abstract

BACKGROUND: There are numerous studies of medication adherence in a variety of chronic diseases including Parkinson's disease; however, there are no such studies in patients with essential tremor (ET). This study aimed to (1) present self-report data on medication adherence in ET cases, (2) examine the demographic and clinical factors that might be associated with lower medication adherence.
METHODS: 151 ET cases were enrolled in a clinical-epidemiological study at Columbia University. An 11-item medication adherence questionnaire, modeled after the Morisky medication adherence questionnaire, was administered.
RESULTS: Seventy-three (48.3%) of 151 cases were taking daily medication for ET. One-third (24/73; 32.9%) of cases reported that they sometimes forgot to take their medication, and 1 in 5 (15/73; 20.5%) reported missed doses within the past week. Most striking was that nearly 1 in 4 (17/73; 23.3%) reported that there were whole days in the past two weeks in which they had not taken their medication. A factor analysis revealed four factors that captured different aspects of non-adherence. Higher non-adherence was associated with more depressive symptoms, younger age, and less severe tremor but was not associated with type or number of ET medications.
CONCLUSIONS: Approximately one in four ET patients reported whole days in the past two weeks in which they had not taken their medication. It is possible that this relatively high rate of non-adherence could be a function of the poor therapeutic efficacy of the medications currently available to treat ET.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adherence; Clinical; Compliance; Epidemiology; Essential tremor; Treatment

Mesh:

Year:  2014        PMID: 25523964      PMCID: PMC4306620          DOI: 10.1016/j.parkreldis.2014.12.001

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  23 in total

Review 1.  How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor.

Authors:  Elan D Louis; Joaquim J Ferreira
Journal:  Mov Disord       Date:  2010-04-15       Impact factor: 10.338

2.  Validation of the Osteoporosis-Specific Morisky Medication Adherence Scale in long-term users of bisphosphonates.

Authors:  Kristi Reynolds; Hema N Viswanathan; Paul Muntner; Teresa N Harrison; T Craig Cheetham; Jin-Wen Y Hsu; Deborah T Gold; Stuart Silverman; Andreas Grauer; Donald E Morisky; Cynthia D O'Malley
Journal:  Qual Life Res       Date:  2014-03-07       Impact factor: 4.147

3.  Self-reported adherence versus pill count in Parkinson's disease: the NET-PD experience.

Authors:  Jordan J Elm; Cornelia Kamp; Barbara C Tilley; Paulo Guimaraes; Debbie Fraser; Patricia Deppen; Alicia Brocht; Chris Weaver; Susan Bennett
Journal:  Mov Disord       Date:  2007-04-30       Impact factor: 10.338

4.  Survey of medication usage patterns among essential tremor patients: movement disorder specialists vs. general neurologists.

Authors:  Nancy L Diaz; Elan D Louis
Journal:  Parkinsonism Relat Disord       Date:  2010-08-05       Impact factor: 4.891

5.  Age of onset: can we rely on essential tremor patients to report this? Data from a prospective, longitudinal study.

Authors:  Elan D Louis
Journal:  Neuroepidemiology       Date:  2012-10-24       Impact factor: 3.282

6.  Essential tremor 10, 20, 30, 40: clinical snapshots of the disease by decade of duration.

Authors:  E D Louis; M Gerbin; M Galecki
Journal:  Eur J Neurol       Date:  2013-03-21       Impact factor: 6.089

7.  Sex differences in barriers to antihypertensive medication adherence: findings from the cohort study of medication adherence among older adults.

Authors:  Elizabeth Holt; Cara Joyce; Adriana Dornelles; Donald Morisky; Larry S Webber; Paul Muntner; Marie Krousel-Wood
Journal:  J Am Geriatr Soc       Date:  2013-03-25       Impact factor: 5.562

8.  Factor analysis of motor and nonmotor signs in essential tremor: are these signs all part of the same underlying pathogenic process?

Authors:  Elan D Louis
Journal:  Neuroepidemiology       Date:  2009-04-08       Impact factor: 3.282

9.  Adherence to antiparkinson medication in a multicenter European study.

Authors:  Donald Grosset; Angelo Antonini; Margherita Canesi; Gianni Pezzoli; Andrew Lees; Karen Shaw; Esther Cubo; Pablo Martinez-Martin; Olivier Rascol; Laurence Negre-Pages; Ana Senard; Johannes Schwarz; Karl Strecker; Heinz Reichmann; Alexander Storch; Matthias Löhle; Fabrizio Stocchi; Katherine Grosset
Journal:  Mov Disord       Date:  2009-04-30       Impact factor: 10.338

10.  Predictive validity of a medication adherence measure in an outpatient setting.

Authors:  Donald E Morisky; Alfonso Ang; Marie Krousel-Wood; Harry J Ward
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-05       Impact factor: 2.885

View more
  4 in total

Review 1.  Emerging strategies in the management of essential tremor.

Authors:  Peter Hedera
Journal:  Ther Adv Neurol Disord       Date:  2016-11-30       Impact factor: 6.570

2.  The Hidden Burden of Disease and Treatment Experiences of Patients with Essential Tremor: A Retrospective Claims Data Analysis.

Authors:  Christine Vetterick; Kelly E Lyons; Lillian G Matthews; Robert Pendal; Bernard Ravina
Journal:  Adv Ther       Date:  2022-10-14       Impact factor: 4.070

Review 3.  Non-invasive Central and Peripheral Stimulation: New Hope for Essential Tremor?

Authors:  Moussa A Chalah; Jean-Pascal Lefaucheur; Samar S Ayache
Journal:  Front Neurosci       Date:  2015-11-18       Impact factor: 4.677

Review 4.  The Effectiveness of Transcranial Brain Stimulation in Improving Clinical Signs of Hyperkinetic Movement Disorders.

Authors:  Ignacio Obeso; Antonio Cerasa; Aldo Quattrone
Journal:  Front Neurosci       Date:  2016-01-07       Impact factor: 4.677

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.